Status: current, Defined. Date: 31-Aug 2018. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
2633421000168117 | Piptaz 4 g/0.5 g (AFT) (piperacillin 4 g + tazobactam 500 mg) powder for injection, 1 x 4.5 g vial (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
2633431000168119 | Piptaz 4 g/0.5 g (AFT) powder for injection, 4.5 g vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Piptaz 4 g/0.5 g (AFT) powder for injection, 4.5 g vial | Is a | trade product pack | true | Inferred relationship | Some | ||
Piptaz 4 g/0.5 g (AFT) powder for injection, 4.5 g vial | Is a | piperacillin 4 g + tazobactam 500 mg injection, 4.5 g vial | true | Inferred relationship | Some | ||
Piptaz 4 g/0.5 g (AFT) powder for injection, 4.5 g vial | has TPUU | Piptaz 4 g/0.5 g (AFT) powder for injection, 4.5 g vial | true | Inferred relationship | Some | 1 | |
Piptaz 4 g/0.5 g (AFT) powder for injection, 4.5 g vial | has TP | Piptaz 4 g/0.5 g (AFT) | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Piptaz 4 g/0.5 g (AFT) powder for injection, 4.5 g vial | Is a | True | Piptaz 4 g/0.5 g (AFT) powder for injection, 4.5 g vial | Inferred relationship | Some |
Reference Sets
Trade product pack reference set